Abstract
BackgroundIn obese adult patients, estimates of ideal body weight (IBW) or adjusted body weight (AdjBW) are often used as drug dose scalars. Many formulas for estimating IBW have been derived, but it is not known which, if any, is the most appropriate as a dose scalar. The objective of this study was to assess the association of methods of estimating IBW and AdjBW with measured body composition in obese adults.MethodsThis was a secondary analysis of an existing dataset. A pooled dataset from the United States’ National Health and Nutrition Examination Surveys, including adults with a BMI ≥30kg/m2 (n=10,606), was used to evaluate methods of estimating IBW and AdjBW. The estimates were evaluated against measured lean body weight (LBW). The primary outcome measure was the proportion of IBW or AdjBW estimates within 10% and 20% of measured LBW (P10 and P20), used as an indicator of the strength of association with body composition.ResultsSeventeen methods of estimating IBW, and one method of estimating AdjBW, were identified. None of these methods were found to have a consistent association with LBW. P10s for male participants varied from 56.4% to 72.7% and for females from 23.1% to 57.7%. Performance of the formulas was also very inconsistent between BMI classes.ConclusionsWeight-based drug doses calculated using IBW or AdjBW cannot be consistent with body composition: some patients will be underdosed and others overdosed. Although IBW and AdjBW are commonly used in clinical practice, their use as dose scalars should be reconsidered.